Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.
Schinstock CA, Mannon RB, Budde K, Chong AS, Haas M, Knechtle S, Lefaucheur C, Montgomery RA, Nickerson P, Tullius SG, Ahn C, Askar M, Crespo M, Chadban SJ, Feng S, Jordan SC, Man K, Mengel M, Morris RE, O'Doherty I, Ozdemir BH, Seron D, Tambur AR, Tanabe K, Taupin JL, O'Connell PJ. Schinstock CA, et al. Transplantation. 2020 May;104(5):911-922. doi: 10.1097/TP.0000000000003095. Transplantation. 2020. PMID: 31895348 Free PMC article. Review.
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement.
Stegall MD, Troy Somerville K, Everly MJ, Mannon RB, Gaber AO, First MR, Agashivala N, Perez V, Newell KA, Morris RE, Sudan D, Romero K, Eremenco S, Mattera M, Spear N, Porter AC, O'Doherty I. Stegall MD, et al. Am J Transplant. 2019 Mar;19(3):625-632. doi: 10.1111/ajt.15214. Epub 2019 Jan 23. Am J Transplant. 2019. PMID: 30549395 Free article.
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting report.
Mannon RB, Morris RE, Abecassis M, Axelrod D, Bala S, Friedman GS, Heeger PS, Lentine KL, Loupy A, Murphy B, Nickerson P, Sarwal M, O'Doherty I, Spear N, Karpen SR. Mannon RB, et al. Among authors: o doherty i. Am J Transplant. 2020 Jun;20(6):1495-1502. doi: 10.1111/ajt.15833. Epub 2020 Mar 17. Am J Transplant. 2020. PMID: 32090461 Free article.
The Role of Patient-reported Outcomes and Medication Adherence Assessment in Patient-focused Drug Development for Solid Organ Transplantation.
Karpen SR, Klein A, Alloway RR, Albrecht R, Belen O, Campbell M, Kluetz P, Minasian LM, Mitchell SA, O'Doherty I, Papadopoulos E, Sapir-Pichhadze R, Spear N, van Gelder T, Velidedeoglu E, Page CA, Everly MJ. Karpen SR, et al. Among authors: o doherty i. Transplantation. 2021 May 1;105(5):941-944. doi: 10.1097/TP.0000000000003556. Transplantation. 2021. PMID: 33901129 No abstract available.
Qualifying a novel clinical trial endpoint (iBOX) predictive of long-term kidney transplant outcomes.
Klein A, Loupy A, Stegall M, Helanterä I, Kosinski L, Frey E, Aubert O, Divard G, Newell K, Meier-Kriesche HU, Mannon RB, Dumortier T, Aggarwal V, Podichetty JT, O'Doherty I, Gaber AO, Fitzsimmons WE; Transplant Therapeutics Consortium. Klein A, et al. Among authors: o doherty i. Am J Transplant. 2023 Oct;23(10):1496-1506. doi: 10.1016/j.ajt.2023.04.018. Epub 2023 Sep 18. Am J Transplant. 2023. PMID: 37735044
Qualifying a Novel Clinical Trial Endpoint (iBOX) Predictive of Long-Term Kidney Transplant Outcomes.
Klein A, Loupy A, Stegall M, Helanterä I, Kosinski L, Frey E, Aubert O, Divard G, Newell K, Meier-Kriesche HU, Mannon R, Dumortier T, Aggarwal V, Podichetty JT, O'Doherty I, Gaber AO, Fitzsimmons WE. Klein A, et al. Among authors: o doherty i. Transpl Int. 2023 Sep 25;36:11951. doi: 10.3389/ti.2023.11951. eCollection 2023. Transpl Int. 2023. PMID: 37822449 Free PMC article.
Longitudinal estimated glomerular filtration rate (eGFR) modeling in long-term renal function to inform clinical trial design in kidney transplantation.
Kosinski L, Frey E, Klein A, O'Doherty I, Romero K, Stegall M, Helanterä I, Gaber AO, Fitzsimmons WE, Aggarwal V; Transplant Therapeutics Consortium (TTC). Kosinski L, et al. Among authors: o doherty i. Clin Transl Sci. 2023 Sep;16(9):1680-1690. doi: 10.1111/cts.13579. Epub 2023 Jul 10. Clin Transl Sci. 2023. PMID: 37350196 Free PMC article.
Leveraging Real-World Data for EMA Qualification of a Model-Based Biomarker Tool to Optimize Type-1 Diabetes Prevention Studies.
Podichetty JT, Lang P, O'Doherty IM, David SE, Muse RN, Karpen SR, Song LS, Romero K, Burton JK; Type-1 Diabetes Consortium (T1DC). Podichetty JT, et al. Among authors: o doherty im. Clin Pharmacol Ther. 2022 May;111(5):1133-1141. doi: 10.1002/cpt.2559. Epub 2022 Mar 11. Clin Pharmacol Ther. 2022. PMID: 35276013 Free PMC article.
Effective Data Sharing as a Conduit for Advancing Medical Product Development.
Karpen SR, White JK, Mullin AP, O'Doherty I, Hudson LD, Romero K, Sivakumaran S, Stephenson D, Turner EC, Larkindale J. Karpen SR, et al. Among authors: o doherty i. Ther Innov Regul Sci. 2021 May;55(3):591-600. doi: 10.1007/s43441-020-00255-8. Epub 2021 Jan 4. Ther Innov Regul Sci. 2021. PMID: 33398663 Free PMC article. Review.
Consortium-based approach to receiving an EMA qualification opinion on the use of islet autoantibodies as enrichment biomarkers in type 1 diabetes clinical studies.
Karpen SR, Dunne JL, Frohnert BI, Marinac M, Richard C, David SE, O'Doherty IM; Type 1 Diabetes Consortium. Karpen SR, et al. Among authors: o doherty im. Diabetologia. 2023 Mar;66(3):415-424. doi: 10.1007/s00125-022-05751-0. Epub 2022 Jul 22. Diabetologia. 2023. PMID: 35867129 Free PMC article. Review.
18 results